Rotor Termination Is Critically Dependent on Kinetic Properties of I Kur Inhibitors in an In Silico Model of Chronic Atrial Fibrillation
暂无分享,去创建一个
Hugo A. Katus | Mathias Wilhelms | Olaf Dössel | Gunnar Seemann | Eberhard P. Scholz | Paola Carrillo-Bustamante | Edgar Zitron | Fathima Fischer
[1] Yoshihisa Kurachi,et al. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling. , 2008, American journal of physiology. Heart and circulatory physiology.
[2] Vincent Heuveline,et al. Framework for Modular, Flexible and Efficient Solving the Cardiac Bidomain Equations Using PETSc , 2010 .
[3] M. Allessie,et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. , 2000, Cardiovascular research.
[4] R F Bosch,et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation. , 1999, Cardiovascular research.
[5] M. Allessie,et al. Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat. , 2011, Cardiovascular research.
[6] 辻前 賢司. In silico study on the effects of I[Kur] block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling , 2009 .
[7] Stef Zeemering,et al. Loss of Continuity in the Thin Epicardial Layer Because of Endomysial Fibrosis Increases the Complexity of Atrial Fibrillatory Conduction , 2013, Circulation. Arrhythmia and electrophysiology.
[8] Martin Bienengraeber,et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. , 2006, Human molecular genetics.
[9] C. Regan,et al. In Vivo Antiarrhythmic and Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide , 2005, Journal of Pharmacology and Experimental Therapeutics.
[10] José Jalife,et al. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. , 2005, Biophysical journal.
[11] Daniel Sundström,et al. Mathematics in industry , 1985 .
[12] José Jalife,et al. Mechanisms of Atrial Fibrillation Termination by Pure Sodium Channel Blockade in an Ionically-Realistic Mathematical Model , 2005, Circulation research.
[13] Kenneth D Anderson,et al. In Vivo Cardiac Electrophysiologic and Antiarrhythmic Effects of an Isoquinoline IKur Blocker, ISQ-1, in Rat, Dog, and Nonhuman Primate , 2007, Journal of cardiovascular pharmacology.
[14] U Schotten,et al. “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat , 2004, Circulation.
[15] Henggui Zhang,et al. 3D virtual human atria: A computational platform for studying clinical atrial fibrillation. , 2011, Progress in biophysics and molecular biology.
[16] L. J. Leon,et al. Cholinergic Atrial Fibrillation in a Computer Model of a Two-Dimensional Sheet of Canine Atrial Cells With Realistic Ionic Properties , 2002, Circulation research.
[17] C. Antzelevitch,et al. Can inhibition of IKur promote atrial fibrillation? , 2008, Heart rhythm.
[18] C. Regan,et al. In Vivo Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker, (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide, in Rat and Nonhuman Primate , 2006, Journal of Pharmacology and Experimental Therapeutics.
[19] Stanley Nattel,et al. Innovative approaches to anti-arrhythmic drug therapy , 2006, Nature Reviews Drug Discovery.
[20] Mathias Wilhelms,et al. Benchmarking electrophysiological models of human atrial myocytes , 2013, Front. Physio..
[21] F. Fenton,et al. Visualization of spiral and scroll waves in simulated and experimental cardiac tissue , 2008 .
[22] S. Hohnloser,et al. Atrial-selective approaches for the treatment of atrial fibrillation. , 2008, Journal of the American College of Cardiology.
[23] D. Dobrev,et al. Role of I Kur in Controlling Action Potential Shape and Contractility in the Human Atrium Influence of Chronic Atrial Fibrillation , 2004 .
[24] S. Nattel,et al. Cardiac Ultrarapid Delayed Rectifiers , 1999, Cellular Physiology and Biochemistry.
[25] S. Hohnloser,et al. New Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation , 2008, Herz Kardiovaskuläre Erkrankungen.
[26] S Nattel,et al. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model. , 1999, Cardiovascular research.
[27] F. Fenton,et al. Multiple mechanisms of spiral wave breakup in a model of cardiac electrical activity. , 2002, Chaos.
[28] Khellil Sefiane,et al. On the Effect of an Atmosphere of Nitrogen on the Evaporation of Sessile Droplets of Water , 2010 .
[29] S. Nattel,et al. Cardiac ultrarapid delayed rectifiers: a novel potassium current family o f functional similarity and molecular diversity. , 1999, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.
[30] Charles Antzelevitch,et al. Reinduction of Atrial Fibrillation Immediately After Termination of the Arrhythmia Is Mediated by Late Phase 3 Early Afterdepolarization–Induced Triggered Activity , 2003, Circulation.
[31] J. Mcanulty,et al. Electrophysiologic predictors of the recurrence of persistent atrial fibrillation within 30 days of cardioversion. , 2004, The American journal of cardiology.
[32] D. Dobrev,et al. Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation , 2004, Circulation.
[33] Nathalie Virag,et al. Wavelength and vulnerability to atrial fibrillation: Insights from a computer model of human atria. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[34] B. Fermini,et al. Novel, Potent Inhibitors of Human Kv1.5 K+ Channels and Ultrarapidly Activating Delayed Rectifier Potassium Current , 2006, Journal of Pharmacology and Experimental Therapeutics.
[35] F. Hornero,et al. A Three-Dimensional Human Atrial Model with Fiber Orientation. Electrograms and Arrhythmic Activation Patterns Relationship , 2013, PloS one.
[36] S. Gardell,et al. Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia. , 2009, Journal of medicinal chemistry.
[37] S. Nattel. New ideas about atrial fibrillation 50 years on , 2002, Nature.
[38] A. Kadish,et al. Effect of electrogram characteristics on the relationship of dominant frequency to atrial activation rate in atrial fibrillation. , 2006, Heart rhythm.
[39] Omer Berenfeld,et al. Heterogeneous atrial wall thickness and stretch promote scroll waves anchoring during atrial fibrillation. , 2012, Cardiovascular research.
[40] Mathias Wilhelms,et al. Atrial fibrillation-based electrical remodeling in a computer model of the human atrium , 2010, 2010 Computing in Cardiology.
[41] Stanley Nattel,et al. Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications , 2008, Circulation. Arrhythmia and electrophysiology.
[42] Mark Potse,et al. Electrical Conduction in Canine Pulmonary Veins: Electrophysiological and Anatomic Correlation , 2002, Circulation.